Press releases

(Français) Un retour prometteur pour la thalidomide

Press release | 06 Apr 2010 - 14h54 | By INSERM PRESS OFFICE
Circulation, metabolism, nutrition

thalidomide-fig-1 Vaisseaux sanguins

TO CITE THIS POST :
Press release – Inserm press room (Français) Un retour prometteur pour la thalidomide Link : http://presse.inserm.fr/en/francais-un-retour-prometteur-pour-la-thalidomide/16107/
Medias
Researcher Contact

Franck Lebrin
Unité Inserm 833 “Angiogénèse embryonnaire et pathologique”
01.44.27.16.89

Press Contact

presse@inserm.fr
01.44.23.60.98

Sources

“Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia”
Franck Lebrin1, Samly Srun1, Karine Raymond2, Sabrina Martin1, Stieneke van den Brink3, Catarina Freitas1, Christiane Bréant1, Thomas Mathivet1, Bruno Larrivée1, Jean-Léon Thomas4, Helen M Arthur5, Cornelis J J Westermann6, Frans Disch6, Johannes J Mager6, Repke J Snijder6, Anne Eichmann1,8 & Christine L Mummery7,8

(1) Institut National de la Santé et de la Recherche Médicale U833, Collège de France, Paris, France
(2) Institut Curie, Centre de Recherche, Centre National de la Recherche Scientifique UMR144, Paris, France
(3) Hubrecht Institute, Developmental Biology and Stem Cell Research, Utrecht, the Netherlands
(4) Institut National de la Santé et de la Recherche Médicale U711, Paris, France
(5) Institute of Human Genetics, International Centre for Life, Newcastle University, Newcastle, UK
(6) St Antonius Hospital, Nieuwegein, the Netherlands
(7) Department of Anatomy and Embryology, Leiden University Medical Centre, Leiden, the Netherlands
(8) These authors contributed equally to this work.

Advance Online Publication on Nature Medicine‘s website on 04 April 2010

fermer
fermer
RSS Youtube